Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT07099534. We help you review the study, but cannot decide medical eligibility.
Not Yet RecruitingNCT07099534
Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder
This study is not yet recruiting. It focuses on personality disorders and currently lists study information in France.
Personality disorders, Borderline personalityDrugFrom 18 Years to 65 Years
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Toulouse, FranceSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: September 1, 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 38
- Sponsor
- University Hospital, Toulouse
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- France
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07099534
- Official title
- Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder: A Pilot Study
Recruitment & locations
Not yet recruitingToulouse
Registry details
Registry conditions (original wording)
Infusion of Ketamine in Severe Borderline Personality Disorder; Borderline Personality Disorder (BPD)
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Toulouse, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not Yet RecruitingNCT07428200
Characterization of the Neural Bases of Mental Imagery in Individuals With Borderline Personality Disorder: An EEG Study
This study is not yet recruiting. It focuses on personality disorders and currently lists study information in France.
CompletedNCT04566601
A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder
This study is completed in the United States, in Australia, in France, .... It focuses on Personality disorders.
CompletedNCT00091650
Olanzapine in people with Borderline Personality Disorder
This study is completed. It focuses on personality disorders and currently lists study information in Belgium, France, Germany, Norway, Portugal, Spain, Sweden, the United Kingdom, and the United States.